Combined treatment of CAPE and docetaxel effectively suppressed the proliferation and survival of docetaxel-resistant PCa cells via inhibition of Bcl-2, c-Myc, AKT2 and induction of metabolism interference. Here, AKT2 is linked to posterior cortical atrophy.